FindTrial
Sign In

A Study on the Safety and Skin Benefits of a Skin Care Formulation in Healthy Men and Women.

To evaluate the in vivo safety and efficacy of skin care formulation in terms of reduction in skin redness, and improvement in skin brightness, skin barrier function, skin moisturization and skin texture on healthy male and female subjects. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106749
Enrollment
36
Registered
2026-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: HONEY GEL FACE WASH: Product is applied on the whole face two times in a day for the period of 28 days. Control Intervention1: Nil: NA

Sponsors

Bio Veda Farmacy Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Indian male & female subjects 2.Healthy subjects 3.Skin is healthy on the studied anatomic unit 4.Having dry dull sensitive skin

Exclusion criteria

Exclusion criteria: 1 For female:- Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2 Having refused to give her assent by not signing the consent form 3 Taking part in another study liable to interfere with this study 4 Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months) 5 Having a progressive asthma (either under treatment or last fit in the last 2 years) 6 Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis) 7 Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 8 Being epileptic. 9 Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 10 Having cutaneous hypersensitivity. 11 Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. 12 Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.

Design outcomes

Primary

MeasureTime frame
Reduction in skin redness, and improvement in skin brightness, skin barrier function, skin moisturization and skin textureTimepoint: Baseline, 30 minutes after application, 24 hours after application, Day 7, Day 28—

Secondary

MeasureTime frame
Improvement in skin smoothness and skin softnessTimepoint: Baseline, 30 minutes after application, 24 hours after application, Day 7, Day 28—

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

niharika@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026